Zobrazeno 1 - 10
of 1 460
pro vyhledávání: '"B, Fink"'
Autor:
Ahilanandan Dushianthan, Howard W. Clark, David Brealey, Danny Pratt, James B. Fink, Jens Madsen, Helen Moyses, Lewis Matthews, Tracy Hussell, Ratko Djukanovic, Martin Feelisch, Anthony D. Postle, Michael P. W. Grocott
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract SARS-CoV-2 directly targets alveolar epithelial cells and can lead to surfactant deficiency. Early reports suggested surfactant replacement may be effective in improving outcomes. The aim of the study to assess the feasibility and efficacy o
Externí odkaz:
https://doaj.org/article/a77d36c23f7d4e1287d0bc5878c169f2
Autor:
Jie Li, Kai Liu, Shan Lyu, Guoqiang Jing, Bing Dai, Rajiv Dhand, Hui-Ling Lin, Paolo Pelosi, Ariel Berlinski, Jordi Rello, Antoni Torres, Charles-Edouard Luyt, Jean-Bernard Michotte, Qin Lu, Gregory Reychler, Laurent Vecellio, Armèle Dornelas de Andrade, Jean-Jacques Rouby, James B. Fink, Stephan Ehrmann
Publikováno v:
Annals of Intensive Care, Vol 13, Iss 1, Pp 1-25 (2023)
Abstract Background Clinical practice of aerosol delivery in conjunction with respiratory support devices for critically ill adult patients remains a topic of controversy due to the complexity of the clinical scenarios and limited clinical evidence.
Externí odkaz:
https://doaj.org/article/ab491201d92241b6a48872417bf266ce
Publikováno v:
Neurology International, Vol 15, Iss 2, Pp 560-568 (2023)
Two derivatives of the numeric rating scale (NRS) and visual analog scale (VAS), namely patient-reported percentage pain reduction (PRPPR) and calculated percentage pain reduction (CPPR), are commonly used when evaluating pain reduction. A small numb
Externí odkaz:
https://doaj.org/article/da3b4bf9d4b6419186739db4ca09badb
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1497 (2023)
Chronic pain is one of the main leading causes of disability in the world at present. A variety in the symptomatology, intensity and duration of this phenomenon has led to an ever-increasing demand of pharmacological treatment and relief. This demand
Externí odkaz:
https://doaj.org/article/9d3b637023774104b472adbeb1b477a6
Autor:
James A. McGrath, Andrew O’Sullivan, Mary Joyce, Miriam A. Byrne, Jie Li, James B. Fink, Ronan MacLoughlin
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
The use of high-flow nasal cannula in the treatment of COVID-19 infected patients has proven to be a valuable treatment option to improve oxygenation. Early in the pandemic, there were concerns for the degree of risk of disease transmission to health
Externí odkaz:
https://doaj.org/article/5f76b4f63bd6417dbec973dc8d390d9d
Publikováno v:
Annals of Intensive Care, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Background Optimal flow settings during high-flow nasal cannula (HFNC) therapy are unknown. We investigated the optimal flow settings during HFNC therapy based on breathing pattern and tidal inspiratory flows in patients with acute hypoxemic
Externí odkaz:
https://doaj.org/article/4c258cda1ebf4bd9a07e7f2f22034c96
Publikováno v:
ERJ Open Research, Vol 8, Iss 4 (2022)
Question addressed by study Administration of aerosol to patients receiving high-flow nasal oxygen (HFNO) ranges from concurrent aerosol delivery by mouthpiece to aerosol via cannula alone. This study examines the conditions to provide optimal aeroso
Externí odkaz:
https://doaj.org/article/ba98fcf164ce491da5cc33967a72df67
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Inhaled epoprostenol (iEPO) has been shown to reduce pulmonary artery pressure and improve oxygenation. iEPO is mainly delivered via a syringe pump with feed tubing connected to a vibrating mesh nebulizer with high or low formulat
Externí odkaz:
https://doaj.org/article/02cb592448354500b17f47ce8dd0cded
Autor:
Cibelle Andrade Lima, Shirley Lima Campos, Monique Pontes Bandeira, Wagner Souza Leite, Daniella Cunha Brandão, Juliana Fernandes, James B. Fink, Armele Dornelas de Andrade
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1466 (2023)
Background: Little has been reported in terms of clinical outcomes to confirm the benefits of nebulized bronchodilators during mechanical ventilation (MV). Electrical Impedance Tomography (EIT) could be a valuable method to elucidate this gap. Object
Externí odkaz:
https://doaj.org/article/9c75f3edcd634374844baac1bcb0ca05
Autor:
Ramandeep Kaur, Tyler T. Weiss, Andrew Perez, James B. Fink, Rongchang Chen, Fengming Luo, Zongan Liang, Sara Mirza, Jie Li
Publikováno v:
Critical Care, Vol 24, Iss 1, Pp 1-13 (2020)
Abstract Coronavirus disease (COVID-19) is an emerging viral infection that is rapidly spreading across the globe. SARS-CoV-2 belongs to the same coronavirus class that caused respiratory illnesses such as severe acute respiratory syndrome (SARS) and
Externí odkaz:
https://doaj.org/article/a647a66f2d714d24b76d8286e92ebea1